Menu
Montecito
Pac Premier
Giving Guide
Loading...
You are here:  Home  >  Latest news  -  Page 555
Latest

Amgen beats analyst estimates for fourth quarter revenue

By   /  Thursday, February 2nd, 2017  /  Central Coast Health Watch, Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen beats analyst estimates for fourth quarter revenue

Thousand Oaks-based biotech giant Amgen reported revenue of $6 billion in the fourth quarter of 2016, besting analyst estimates of $5.74 billion and increasing 8 percent from the fourth quarter of 2015. The world’s largest biotech drug maker posted total revenues of $23 billion on the year, up 6 percent from 2015. Revenue gains were Read More →

Read More →
Latest

Net income down at Deckers Outdoor

By   /  Thursday, February 2nd, 2017  /  Earnings, Latest news, Tri-County Public Companies  /  Comments Off on Net income down at Deckers Outdoor

Deckers Outdoor, a footwear and apparel company based in Goleta, declared $41.03 million in net income for its third quarter 2017, ended Dec. 31, down more than 73 percent from the third quarter of 2016. For the first nine months of its fiscal year, the company earned $21.41 million, down from $145.97 million for the Read More →

Read More →
Latest

Teledyne Technologies reports decline in net income

By   /  Thursday, February 2nd, 2017  /  Earnings, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Teledyne Technologies reports decline in net income

Thousand-Oaks based Teledyne Technologies reported a drop in net income for its fiscal year 2016 over the prior year, with a 7 percent fourth quarter drop in sales to $552.9 million. Net income from continuing operations came to $192.9 million, or $5.43 per diluted share, compared to $198 million in 2015, while total sales fell Read More →

Read More →
Latest

Agilent cancer treatment approved in Europe

By   /  Thursday, February 2nd, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on Agilent cancer treatment approved in Europe

Agilent Technologies, with offices in Carpinteria, announced a product designed to identify previously untreated non-small cell lung cancer patients with a tumor proportion score of 50 percent or more was approved for use in Europe in conjunction with Merck’s Keytruda therapy. Before using the product – called PD-L1 IHC 22C3 pharmDx and developed by Agilent Read More →

Read More →
Latest

MOXI science museum to open doors Feb. 25

By   /  Thursday, February 2nd, 2017  /  Education, Latest news, Nonprofits  /  Comments Off on MOXI science museum to open doors Feb. 25

MOXI, The Wolf Museum of Exploration + Innovation announced it would open Saturday, Feb. 25 at its new 17,000-square-foot space located at 125 State St. in Santa Barbara. Twenty-five years in the making, the museum will offer hands-on science and technology exhibits and expects to attract more than 100,000 guests in its first year. “The entire Read More →

Read More →
Latest

CompuVision, Sagewood announce consolidation

By   /  Tuesday, January 31st, 2017  /  Central Coast Health Watch, Latest news, Technology  /  Comments Off on CompuVision, Sagewood announce consolidation

IT services company CompuVision announced a partnership with health care technology services company Sagewood Systems, both based in Santa Barbara, on Jan. 31. The move will consolidate the companies’ technology, management and communications offerings under the CompuVision brand, it said in a news release, including consulting, enterprise applications and a “hyperconverged infrastructure” system that combines Read More →

Read More →
Latest

Amgen CEO meets with Trump, vows to add 1,600 jobs

By   /  Tuesday, January 31st, 2017  /  Central Coast Health Watch, Latest news  /  Comments Off on Amgen CEO meets with Trump, vows to add 1,600 jobs

Amgen CEO Robert Bradway met with President Donald Trump on Jan. 31 and vowed to add 1,600 jobs, Bloomberg News reported. Trump told biotech leaders at a White House meeting that drug prices needed to come down and he would find a way to streamline the regulatory process. He has discussed having the government negotiate Read More →

Read More →